Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders Mercier I; Jasmin JF; Pavlides S; Minetti C; Flomenberg N; Pestell RG; Frank PG; Sotgia F; Lisanti MPLab Invest 2009[Jun]; 89 (6): 614-23Here we review the clinical and translational implications of the caveolin gene family for understanding the pathogenesis of human diseases, including breast and prostate cancers, pulmonary hypertension, cardiomyopathy, diabetes, and muscular dystrophy. Detailed phenotypic analysis of caveolin knockout mice has served to highlight the crucial role of a caveolin deficiency in the pathogenesis of many human disease processes. Mutations in the human caveolin genes are associated with a number of established genetic disorders (such as breast cancer, lipodystrophy, muscular dystrophy, and cardiomyopathy), making the caveolins important and novel targets for drug development. The implementation of new strategies for caveolin replacement therapy-including caveolin mimetic peptides-is ongoing.|Adult Stem Cells/metabolism[MESH]|Animals[MESH]|Breast Neoplasms/drug therapy/metabolism[MESH]|Cardiomyopathies/metabolism[MESH]|Caveolae/metabolism[MESH]|Caveolins/biosynthesis/genetics/*physiology[MESH]|Diabetes Mellitus/drug therapy/metabolism[MESH]|Humans[MESH]|Hypertension, Pulmonary/drug therapy/metabolism[MESH]|Male[MESH]|Mice[MESH]|Muscular Dystrophies/drug therapy/metabolism[MESH]|Mutation[MESH]|Peptides/therapeutic use[MESH]|Prostatic Neoplasms/drug therapy/metabolism[MESH]|Signal Transduction[MESH] |